INDP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Indaptus Therapeutics Inc (INDP) is not a strong buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with declining net income and EPS, and there are no significant positive catalysts or trading signals to suggest immediate growth potential. Additionally, there is no recent news, analyst ratings, or congress trading data to support a bullish outlook.
The MACD is positively expanding, indicating a slight bullish momentum. RSI is neutral at 64.388, and moving averages are converging, showing no clear trend. Key resistance levels are at 2.113 and 2.245, while support levels are at 1.685 and 1.553.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance with declining net income (-3.06% YoY) and EPS (-67.04% YoY). No significant trading trends or positive sentiment indicators.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$2,975,117 (-3.06% YoY), and EPS fell sharply to -2.98 (-67.04% YoY). Gross margin remained at 0.
No data available for analyst ratings or price target changes.
